Gilead questions WHO study that cast doubts on drug’s COVID-19 benefits

Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.

Read the full article here

Related Articles